SIX-listed Santhera Pharmaceuticals has signed an exclusive licensing agreement with biopharma company Nxera Pharma for the development, manufacturing and commercialisation across Japan, South Korea, Australia and New Zealand of Agamree, a prescription medicine used to
Tags :Oliver P. Kronenberg
Global pharmaceuticals company, Vifor Pharma Group, has appointed group general counsel Oliver P. Kronenberg (pictured) as a member of the Vifor Pharma Executive Committee, effective 1 February 2022. Oliver P. Kronenberg joined Vifor Pharma in 2008. Following his